middle.news
Echo IQ Advances US Market Bid with FDA Submission for Heart Failure AI Tool
8:30am on Monday 15th of December, 2025 AEDT
•
Healthcare
Read Story
Echo IQ Advances US Market Bid with FDA Submission for Heart Failure AI Tool
8:30am on Monday 15th of December, 2025 AEDT
Key Points
FDA 510(k) submission lodged for EchoSolv HF
Clinical validation shows 99.5% sensitivity and 91.0% specificity
Targets US heart failure market valued at approximately $60 billion
Heart failure affects 1 in 4 Americans and drives 17% of US healthcare costs
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Echoiq (ASX:EIQ)
OPEN ARTICLE